165 related articles for article (PubMed ID: 14694443)
1. Expression of the p16INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines.
Honoki K; Tsujiuchi T; Mori T; Yoshitani K; Tsutsumi M; Takakura Y; Mii Y
Mol Carcinog; 2004 Jan; 39(1):10-4. PubMed ID: 14694443
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y
Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542
[TBL] [Abstract][Full Text] [Related]
4. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
[TBL] [Abstract][Full Text] [Related]
6. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
8. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis].
Chen M; Cui PG; Yao X; Cao YH; Gong JQ; Li AS; Chen ZQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):674-6. PubMed ID: 18067081
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
Bender CM; Pao MM; Jones PA
Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
[TBL] [Abstract][Full Text] [Related]
11. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
12. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
[TBL] [Abstract][Full Text] [Related]
15. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
[TBL] [Abstract][Full Text] [Related]
16. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.
Gonzalgo ML; Hayashida T; Bender CM; Pao MM; Tsai YC; Gonzales FA; Nguyen HD; Nguyen TT; Jones PA
Cancer Res; 1998 Mar; 58(6):1245-52. PubMed ID: 9515812
[TBL] [Abstract][Full Text] [Related]
17. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
18. Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis.
Kitazawa R; Kitazawa S
Mol Endocrinol; 2007 Jan; 21(1):148-58. PubMed ID: 17008384
[TBL] [Abstract][Full Text] [Related]
19. Distinct susceptibility of induction of methylation of p16ink4a and p19arf CpG islands by X-radiation and chemical carcinogen in mice.
Yang C; Gu L; Deng D
Mutat Res Genet Toxicol Environ Mutagen; 2014 Jul; 768():42-50. PubMed ID: 24780116
[TBL] [Abstract][Full Text] [Related]
20. p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation.
Zheng QH; Ma LW; Zhu WG; Zhang ZY; Tong TJ
J Cell Biochem; 2006 Aug; 98(5):1230-48. PubMed ID: 16514663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
